SCHEMBL9998644

SCHEMBL9998644

CC(=O)OCC(=Cc1ccc(F)cc1)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.43
CYP2C9 P11712 2/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
CYP3A4 P08684 1/20 0.41
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.39
CNR2 P34972 1/20 0.39
PAM P19021 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998643 1.00 ALDH1A1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997388 0.90 ALDH1A1 (0.50) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997387 0.90 ALDH1A1 (0.50) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997509 0.88 KMT2A (0.48) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997511 0.88 KMT2A (0.48) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997518 0.86 ALDH1A1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997617 0.86 ALDH1A1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9998193 0.86 L3MBTL1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9997615 0.86 ALDH1A1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA
SCHEMBL9998195 0.86 L3MBTL1 (0.44) ALDH1A1KMT2ACYP2C9MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ALDH1A1 160/4885KMT2A 2324/4885CYP2C9 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.